Machado-Joseph disease also called spinocerebellar ataxia type 3 (MJD/SCA3) is a hereditary and neurodegenerative movement disorder caused by ataxin-3 with a polyglutamine expansion (mutant ataxin-3). Neuronal loss in MJD/SCA3 is associated with a mutant ataxin-3 toxic fragment. Defining mutant ataxin-3 proteolytic site(s) could facilitate the identification of the corresponding enzyme(s). Previously, we reported a mutant ataxin-3 mjd1a fragment in the brain of transgenic mice (Q71) that contained epitopes C-terminal to amino acid 220. In this study, we generated and characterized neuroblastoma cells and transgenic mice expressing mutant ataxin-3 mjd1a lacking amino acids 190-220 (deltaQ71). Less deltaQ71 than Q71 fragments were detected in the cell but not mouse model. The transgenic mice developed an MJD/SCA3-like phenotype and their brain homogenates had a fragment containing epitopes C-terminal to amino acid 220. Our results support the toxic fragment hypothesis and narrow the mutant ataxin-3 cleavage site to the N-terminus of amino acid 190.
Introduction
Machado-Joseph disease (MJD), also called spinocerebellar ataxia type 3 (SCA3), is the most common dominantly inherited cerebellar ataxia in many countries (Matilla et al., 1995; Schols et al., 1995; Durr et al., 1996; Silveira et al., 1998; Jardim et al., 2001) . The signs and symptoms include progressive postural instability, gait and limb ataxia, weight loss and, in severe cases, premature death (Fowler, 1984; Sudarsky and Coutinho, 1995) . The neuronal loss occurs in selective brains regions (Fowler, 1984; Sudarsky and Coutinho, 1995; Durr et al., 1996) . MJD/SCA3 is caused by ataxin-3 with a stretch of 54-84 consecutive glutamines (mutant ataxin-3); normal ataxin-3 has 14-37 (Kawaguchi et al., 1994; van Alfen et al., 2001 ). Ataxin-3 has functional domains ( Fig. 1) and several isoforms resulting from alternative splicing but only mjd1a and ataxin-3c have extended polyglutamines (Kawaguchi et al., 1994; Schmidt et al., 1998; Ichikawa et al., 2001 ). Mutant ataxin-3 expression is widespread (Ross, 1995; Nishiyama et al., 1996; Paulson et al., 1997a; Wang et al., 1997; Schmidt et al., 1998; Trottier et al., 1998) , although neuronal loss is selective.
The C-terminal portion of mutant ataxin-3 that includes the polyglutamine stretch is more toxic than the entire protein, in cell and animal models (Ikeda et al., 1996; Paulson et al., 1997b; Warrick et al., 1998; Yoshizawa et al., 2000; Hara et al., 2001; Goti et al., 2004) . Thus, selective neuronal loss in MJD/SCA3 was proposed to stem from a toxic cleavage fragment of mutant ataxin-3 (Ikeda et al., 1996) . Indeed, a mutant ataxin-3 putative-cleavage fragment was identified in transfected cell lines (Yamamoto et al., 2001; Berke et al., 2004) . We provided the first evidence of such fragment in brain of an MJD/SCA3-like mouse model and postmortem MJD/SCA3
